Telehealth

Iris Telehealth Acquires innovaTel from Quartet Health

Iris Telehealth has acquired innovaTel, a now-former division of Quartet Health, in what could be the first of other acquisitions by the company. The deal marks a notable consolidation in the health care enterprise-focused digital behavioral health space. It gives Iris Telehealth additional scale via several overlapping markets it shared with innovaTel. Before the deal, […]

Iris Telehealth Acquires innovaTel from Quartet Health Read More »

23andMe Has Been Quietly Exploring a Possible Sale of Its Telehealth Business, Lemonaid

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI. It’s

23andMe Has Been Quietly Exploring a Possible Sale of Its Telehealth Business, Lemonaid Read More »

Top Telehealth Companies by Market Share

The COVID-19 pandemic dramatically accelerated the adoption of telehealth technology by hospitals and healthcare organizations across the country. While telehealth usage has fallen from pandemic highs, the technology appears poised to stay as another tool in the provider’s toolbox to treat patients, particularly those in the mental healthcare space. Here, Definitive Healthcare has listed the top 10 telehealth companies

Top Telehealth Companies by Market Share Read More »

DEA Releases Special Registration Framework, Telehealth Final Rule

Substance use disorder (SUD) treatment providers who prescribe medications for opioid use disorder (MOUD) via telehealth have received some good news. The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced a final rule that allows clinicians to prescribe buprenorphine via telehealth or audio-only telehealth visits for up to six

DEA Releases Special Registration Framework, Telehealth Final Rule Read More »

Inside Avel eCare’s $21M Acquisition of Amwell’s Psychiatric Business

Amwell (NYSE: AMWL) has sold its virtual psychiatric business to clinician-to-clinician telehealth provider Avel eCare for $21 million. The deal allows Amwell and Avel to focus on their core operations, Avel’s CEO Doug Duskin told Behavioral Health Business. “[Amwell is] focusing on technology as their primary service,” Duskin said. “We’re more of a technology-enabled service

Inside Avel eCare’s $21M Acquisition of Amwell’s Psychiatric Business Read More »

Scroll to Top